Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Telesis Bio

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis
From Telesis Bio
Via Business Wire
Tickers OTC TBIO
Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis
From Telesis Bio
Via Business Wire
Tickers OTC TBIO
Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports First Quarter 2024 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Reverse Stock Split
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Third Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Appoints William J. Kullback Chief Financial Officer
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Second Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Jefferies Healthcare Conference 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Secures Financing of $28.0 Million
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at SynBioBeta 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports First Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Telesis Bio to Present at Festival of Biologics Conference
From Telesis Bio
Via GlobeNewswire
Tickers TBIO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.